1117454

Novocol Pharmaceutical of Canada, Inc. — FEI 3002807757

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 30, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Cambridge (Canada)

Additional Details

Postmarket Adverse Drug Experience (PADE)